| Oncogenic EGFR signaling activates an mTORC2–NF-κB pathway that promotes chemotherapy resistance K Tanaka, I Babic, D Nathanson, D Akhavan, D Guo, B Gini, J Dang, ... Cancer discovery 1 (6), 524-538, 2011 | 334 | 2011 |
| The NF-κB pathway and cancer stem cells AL Rinkenbaugh, AS Baldwin Cells 5 (2), 16, 2016 | 257 | 2016 |
| Therapeutically engineered induced neural stem cells are tumour-homing and inhibit progression of glioblastoma JR Bagó, A Alfonso-Pecchio, O Okolie, R Dumitru, A Rinkenbaugh, ... Nature communications 7 (1), 10593, 2016 | 127 | 2016 |
| IKK/NF-κB signaling contributes to glioblastoma stem cell maintenance AL Rinkenbaugh, PC Cogswell, B Calamini, DE Dunn, AI Persson, ... Oncotarget 7 (43), 69173, 2016 | 51 | 2016 |
| Single-cell evaluation reveals shifts in the tumor-immune niches that shape and maintain aggressive lesions in the breast VC Sinha, AL Rinkenbaugh, M Xu, X Zhou, X Zhang, S Jeter-Jones, ... Nature communications 12 (1), 5024, 2021 | 14 | 2021 |
| Monoallelic deletion of NFKBIA in glioblastoma: when less is more AL Rinkenbaugh, AS Baldwin Cancer cell 19 (2), 163-165, 2011 | 10 | 2011 |
| The NF-kappaB pathway and cancer stem cells. Cells 5 AL Rinkenbaugh, AS Baldwin E16, 2016 | 9 | 2016 |
| Oncogenic EGFR signaling activates an mTORC2-NF-κB pathway that promotes chemotherapy resistance. Cancer Discov. 2011; 1: 524–38. doi: 10.1158/2159-8290 K Tanaka, I Babic, D Nathanson, D Akhavan, D Guo, B Gini, J Dang, ... CD-11-0124.[Europe PMC free article][Abstract][CrossRef][Google Scholar], 0 | 8 | |
| Predictors of success in establishing orthotopic patient-derived xenograft models of triple negative breast cancer GV Echeverria, S Cai, Y Tu, J Shao, E Powell, AB Redwood, Y Jiang, ... Npj Breast Cancer 9 (1), 2, 2023 | 7 | 2023 |
| The NF-κB pathway and cancer stem cells. Cells. 2016; 5: 16 AL Rinkenbaugh, AS Baldwin | 5 | |
| Analysis of spatiotemporal phenotypic heterogeneity in chemoresistant triple negative breast cancer using imaging mass cytometry AL Rinkenbaugh, VC Sinha, GV Echeverria, X Zhang, J Shao, ... Cancer Research 80 (16_Supplement), 1513-1513, 2020 | 1 | 2020 |
| Functionalizing intratumoral signaling heterogeneity in triple negative breast cancer AL Rinkenbaugh, VC Sinha, X Zhang, H Piwnica-Worms Cancer Research 78 (13_Supplement), 2181-2181, 2018 | 1 | 2018 |
| Targeting neddylation and sumoylation in chemoresistant triple negative breast cancer RT Powell, AL Rinkenbaugh, L Guo, S Cai, J Shao, X Zhou, X Zhang, ... NPJ Breast Cancer 10 (1), 37, 2024 | | 2024 |
| PDX models of TNBC established from pre-and post-therapy tumors identify vulnerabilities of resistant disease AL Rinkenbaugh, Y Qi, RT Powell, S Cai, J Shao, FB Hancock, L Guo, ... Cancer Research 84 (6_Supplement), 6620-6620, 2024 | | 2024 |
| Abstract PR01: Analysis of spatiotemporal phenotypic heterogeneity in chemoresistant triple negative breast cancer using imaging mass cytometry AL Rinkenbaugh, VC Sinha, J Shao, X Zhang, GV Echeverria, ... Cancer Research 80 (21_Supplement), PR01-PR01, 2020 | | 2020 |
| Immuno-oncology panel optimization for imaging mass cytometry and digital image analysis of tumor tissues P Rocha, L Solis, E Parra, O Shi, B Mino, VC Sinha, A Rinkenbaugh, ... Cancer Research 80 (16_Supplement), 2679-2679, 2020 | | 2020 |
| Single-cell evaluation to identify tumor-stroma niches driving the transition from in situ to invasive breast cancer VC Sinha, M Xu, AL Rinkenbaugh, X Zhou, X Zhang, H Piwnica-Worms Cancer Research 80 (16_Supplement), 2822-2822, 2020 | | 2020 |
| Investigating triple negative breast cancer phenotypic heterogeneity of human and patient-derived xenograft samples using imaging mass cytometry AL Rinkenbaugh, VC Sinha, X Zhang, J Shao, H Piwnica-Worms Cancer Research 79 (13_Supplement), 4708-4708, 2019 | | 2019 |
| Multiparametric imaging to evaluate human and mouse breast carcinoma in situ VC Sinha, F Yang, AL Rinkenbaugh, X Zhou, X Zhang, II Wistuba, ... MOLECULAR CANCER RESEARCH 16 (8), 92-92, 2018 | | 2018 |
| Abstract B59: Multiparametric imaging to evaluate human and mouse breast carcinoma in situ VC Sinha, F Yang, AL Rinkenbaugh, X Zhou, X Zhang, II Wistuba, ... Molecular Cancer Research 16 (8_Supplement), B59-B59, 2018 | | 2018 |
